These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35246338)

  • 1. Polyvinyl Alcohol Cryogels for Acoustic Characterization of Phase-Change Contrast Agents.
    Durham PG; Kim J; Eltz KM; Caskey CF; Dayton PA
    Ultrasound Med Biol; 2022 May; 48(5):954-960. PubMed ID: 35246338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal and Acoustic Stabilization Of Volatile Phase-Change Contrast Agents Via Layer-By-Layer Assembly.
    Alcaraz PE; Davidson SJ; Shreeve E; Meuschke R; Romanowski M; Witte RS; Porter TR; Matsunaga TO
    Ultrasound Med Biol; 2023 May; 49(5):1058-1069. PubMed ID: 36797095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaporization dynamics of volatile perfluorocarbon droplets: a theoretical model and in vitro validation.
    Doinikov AA; Sheeran PS; Bouakaz A; Dayton PA
    Med Phys; 2014 Oct; 41(10):102901. PubMed ID: 25281982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells.
    Hadinger KP; Marshalek JP; Sheeran PS; Dayton PA; Matsunaga TO
    Ultrasound Med Biol; 2018 Dec; 44(12):2728-2738. PubMed ID: 30228045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaporization Detection Imaging: A Technique for Imaging Low-Boiling-Point Phase-Change Contrast Agents with a High Depth of Penetration and Contrast-to-Tissue Ratio.
    Rojas JD; Dayton PA
    Ultrasound Med Biol; 2019 Jan; 45(1):192-207. PubMed ID: 30482709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcranial activation and imaging of low boiling point phase-change contrast agents through the temporal bone using an ultrafast interframe activation ultrasound sequence.
    Jing B; Kashyap EP; Lindsey BD
    Med Phys; 2020 Sep; 47(9):4450-4464. PubMed ID: 32657429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging.
    Sheeran PS; Wong VP; Luois S; McFarland RJ; Ross WD; Feingold S; Matsunaga TO; Dayton PA
    Ultrasound Med Biol; 2011 Sep; 37(9):1518-30. PubMed ID: 21775049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound.
    Sheeran PS; Luois S; Dayton PA; Matsunaga TO
    Langmuir; 2011 Sep; 27(17):10412-20. PubMed ID: 21744860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro.
    Marshalek JP; Sheeran PS; Ingram P; Dayton PA; Witte RS; Matsunaga TO
    J Control Release; 2016 Dec; 243():69-77. PubMed ID: 27686582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorous-phase iron oxide nanoparticles as enhancers of acoustic droplet vaporization of perfluorocarbons with supra-physiologic boiling point.
    Vezeridis AM; de Gracia Lux C; Barnhill SA; Kim S; Wu Z; Jin S; Lux J; Gianneschi NC; Mattrey RF
    J Control Release; 2019 May; 302():54-62. PubMed ID: 30928487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons.
    Sheeran PS; Luois SH; Mullin LB; Matsunaga TO; Dayton PA
    Biomaterials; 2012 Apr; 33(11):3262-9. PubMed ID: 22289265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Acoustic Activation of Phase Change Contrast Agents With the Activation Pressure Matching Method: A Review.
    Rojas JD; Dayton PA
    IEEE Trans Ultrason Ferroelectr Freq Control; 2017 Jan; 64(1):264-272. PubMed ID: 27740481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle.
    Sheeran PS; Streeter JE; Mullin LB; Matsunaga TO; Dayton PA
    Ultrasound Med Biol; 2013 May; 39(5):893-902. PubMed ID: 23453380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulse sequences for uniform perfluorocarbon droplet vaporization and ultrasound imaging.
    Puett C; Sheeran PS; Rojas JD; Dayton PA
    Ultrasonics; 2014 Sep; 54(7):2024-33. PubMed ID: 24965563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyvinyl alcohol cryogel based vessel mimicking material for modelling the progression of atherosclerosis.
    Malone AJ; Cournane S; Naydenova IG; Fagan AJ; Browne JE
    Phys Med; 2020 Jan; 69():1-8. PubMed ID: 31811996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient acoustic vaporization signatures unique to low boiling point phase change contrast agents enable super-resolution ultrasound imaging without spatiotemporal filtering.
    DeRuiter RM; Markley EN; Rojas JD; Pinton GF; Dayton PA
    AIP Adv; 2020 Oct; 10(10):105124. PubMed ID: 33094029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signatures.
    Sheeran PS; Matsunaga TO; Dayton PA
    Phys Med Biol; 2014 Jan; 59(2):379-401. PubMed ID: 24351961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents.
    Sheeran PS; Rojas JD; Puett C; Hjelmquist J; Arena CB; Dayton PA
    Ultrasound Med Biol; 2015 Mar; 41(3):814-31. PubMed ID: 25619781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focused ultrasound-facilitated brain drug delivery using optimized nanodroplets: vaporization efficiency dictates large molecular delivery.
    Wu SY; Fix SM; Arena CB; Chen CC; Zheng W; Olumolade OO; Papadopoulou V; Novell A; Dayton PA; Konofagou EE
    Phys Med Biol; 2018 Jan; 63(3):035002. PubMed ID: 29260735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D Acoustic Wave Sparsely Activated Localization Microscopy With Phase Change Contrast Agents.
    Riemer K; Tan Q; Morse S; Bau L; Toulemonde M; Yan J; Zhu J; Wang B; Taylor L; Lerendegui M; Wu Q; Stride E; Dunsby C; Weinberg PD; Tang MX
    Invest Radiol; 2024 May; 59(5):379-390. PubMed ID: 37843819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.